Select a page
  • Home
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR
    • Students
    • Alumni
  • Our Team
  • Home
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR
    • Students
    • Alumni
  • Our Team

Fall 2011

The Perfect Remedy

Could drug incubation allow Canada to better compete in the global pharmaceutical industry?
January 4, 2012 | David Stewart and Sabriya Karim
Read as PDF
TAGS
Canada David Stewart Fall 2011 Full Article Growth Strategy Healthcare and Pharmaceuticals National Pharmaceuticals Sabriya Karim Volume 3
CONTACT THE AUTHOR
David Stewart
Sabriya Karim
COMMENTS

Most Read Articles
Shopify: Simplifying the Future of Retail
by Alex Du
Interview: Dean Connor, Sun Life Financial
by Ivey Business Review
Lego: Restructuring, Brick By Brick
by Jerry Wang and Eden Ip
GoPro: Capturing a New Audience
by Gary Wu and Jackie Wang
Calm: The Calm Before the Storm
by Virginia Ling and Stephanie Li
Related Articles
The Big Pharma Bust
by Juthika Thakur
A Healthy Getaway
by David Stewart and Sabriya Karim
Gilead: Cultivating the Pipeline
by Jason Cheung and Dennis Zhan
The Battle Over Your Genes
by Lauren Lee
Revitalizing Medical Care
by Geoff Calder and Nadeem Nathoo
Teva: Don’t Be so Generic
by Sooruj Ghangass and Gordon Sun
About IBR

Ivey Business Review is written, designed, and managed by undergraduate students at the Ivey Business School and is the only publication of its kind in the country. IBR publishes two issues annually in December and April with content created exclusively by students and maintains an active blog, curated by the IBR Editorial Board, with contributions from students and young alumni.

IBR On Twitter
  • We are proud to announce the release of our Spring 2018 issue (https://t.co/rFKOrVi1kL ). Find articles proposing B… https://t.co/VaHpa9wO5n
  • We are proud to announce the release of our Fall 2017 edition, with articles such as a biosimilar strategy for Teva… https://t.co/khESwrfGmU
  • Our feature interview, @mhyattbluecat sold his company for $400M! Find out his thoughts on entrepreneurship here: https://t.co/PL7oqL7BcG
About Ivey

The Ivey Business School at Western University offers undergraduate (HBA) and graduate degree programs (MSc, MBA, Executive MBA and PhD) in addition to non-degree Executive Development programs.

Copyright ® 2020, Ivey Business School | Terms of Use & Privacy Policy